PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0777
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

Oncogenic and Wild-Type Ras Play Divergent Roles in the Regulation of Mitogen-Activated Protein Kinase Signaling

Cancer Discovery
Oncology
2012English

Glutaredoxin Is a Direct Target of Oncogenic Jun

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Structures of Wild-Type and Mutant Human Spermidine/Spermine N1-Acetyltransferase, a Potential Therapeutic Drug Target

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

Annual Review of Immunology
AllergyImmunology
2011English

INPP4B Is Upregulated and Functions as an Oncogenic Driver Through SGK3 in a Subset of Melanomas

Oncotarget
Oncology
2015English

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type Versus Mutated Proteins

ISRN Oncology
2013English

NRAS Q61R , BRAF V600E Immunohistochemistry: A Concomitant Tool for Mutation Screening in Melanomas

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy